Publications by authors named "E Elez"

Claim this Profile
E
Efficacy and safety of atezolizumab plus bevacizumab in MSI-like metastatic colorectal cancer: a multicenter, single-arm, phase II, open-label clinical trial.
E Elez, S Siena, A Sartore-Bianchi, J Ros, F Ciardello

ESMO Open· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Mosperafenib, a novel paradox breaker BRAF inhibitor with potent preclinical activity in BRAF mutated colorectal cancer.
Florian Renner, Jan Eckmann, Cornelia Handl, Jürgen Wichmann, Gabriel Schnetzler

Mol Cancer Ther· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Broad Utility of Ultrasensitive Analysis of ctDNA Dynamics across Solid Tumors Treated with Immunotherapy.
Elena Garralda, Charles Abbott, Alma Calahorro, Oriol Mirallas, Jason Pugh

Clin Cancer Res· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
V
Value contribution of trifluridine/tipiracil with bevacizumab for the treatment of metastatic colorectal cancer in Catalonia using a multicriteria decision analysis.
Candela Calle, Elena Elez, José Luis Manzano, Maria-Estela Moreno-Martinez, Carles Pericay

J Pharm Policy Pract· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Interventional strategies to address burnout in young medical oncologists: results from the Resilience-Spanish Society of Medical Oncology (SEOM) Study and a university hospital experience in Spain.
Vilma Pacheco-Barcia, Berta Obispo, Elia Tomas, Clara Salva de Torres, Teresa Quintanar, Elena Elez

Clin Transl Oncol· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis